Lpl Financial LLC Oncocyte Corp Transaction History

Lpl Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$0.2 - $0.35 $4,020 - $7,036	-20,104 Reduced 13.62%	127,459 $29,000
Q1 2023 May 10, 2023	BUY	$0.2 - $0.49 $1,307 - $3,203	6,538 Added 4.64%	147,563 $51,000
Q4 2022 Feb 07, 2023	BUY	$0.25 - $15.6 $546 - $34,070	2,184 Added 1.57%	141,025 $45,000
Q3 2022 Nov 14, 2022	BUY	$0.76 - $15.98 $22,819 - $479,799	30,025 Added 27.59%	138,841 $101,000
Q2 2022 Aug 12, 2022	BUY	$0.86 - $1.53 $34,400 - $61,200	40,000 Added 58.13%	108,816 $98,000
Q1 2022 May 16, 2022	BUY	$1.15 - $2.25 $33,350 - $65,250	29,000 Added 72.84%	68,816 $103,000
Q4 2021 Feb 14, 2022	BUY	$2.04 - $3.59 $37,719 - $66,379	18,490 Added 86.7%	39,816 $86,000
Q3 2021 Nov 15, 2021	BUY	$3.53 - $5.89 $75,280 - $125,610	21,326 New	21,326 $76,000

1.5M

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $342M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.